FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743207894> ?p ?o ?g. }

• W2743207894 endingPage "6390" @default.
• W2743207894 startingPage "6383" @default.
• W2743207894 abstract "Graves' disease is an autoimmune process in which the thyroid gland is triggered by autoantibodies, resulting in hyperthyroidism. The purpose of the present study is to elucidate whether exon‐1 49 A/G and promoter region 318C/T polymorphisms in the CTLA‐4 gene. This study consisted of 653 eligible patients with Graves' disease. After receiving 131I radionuclide therapy, these patients were classified into the remission and non‐remission groups. A logistic regression‐based model was used to analyze independent factors affecting the patient response to 131I radionuclide therapy. The results showed that CTLA‐4 49 A/G was closely related to the efficacy of 131 I treatment for Graves’ disease (AG + GG vs. AA: OR = 6.543, 95%CI = 2.611 ∼ 16.40, P < 0.001; G vs. A: OR = 3.482, 95%CI = 2.457 ∼ 4.934, P < 0.001). Moreover, the findings revealed that haplotype A‐C ( P < 0.001, OR = 3.592, 95%CI: 2.451 ∼ 5.262) and G‐C ( P < 0.001, OR = 0.282, 95%CI: 0.204 ∼ 0.391) were associated with the efficacy of 131 I therapy in treating Graves’ disease. Logistic regression analysis indicated that thyroid weight (OR = 0.963, 95%CI = 0.944 ∼ 0.982, P < 0.001) and CTLA‐4 exon‐1 49 A/G polymorphism (OR = 0.334, 95%CI = 0.233 ∼ 0.478, P < 0.001) independently affect the efficacy of 131 I therapy in Graves’ disease. These data indicated that CTLA‐4 exon‐1 49 A/G polymorphism may be associated with patient response to radionuclide 131 I therapy in Graves’ disease." @default.
• W2743207894 created "2017-08-17" @default.
• W2743207894 creator A5000868340 @default.
• W2743207894 creator A5003520375 @default.
• W2743207894 creator A5015425896 @default.
• W2743207894 creator A5024332545 @default.
• W2743207894 creator A5026035167 @default.
• W2743207894 creator A5028256671 @default.
• W2743207894 creator A5044622075 @default.
• W2743207894 creator A5047278332 @default.
• W2743207894 creator A5047564239 @default.
• W2743207894 creator A5058986343 @default.
• W2743207894 creator A5059263184 @default.
• W2743207894 creator A5063749738 @default.
• W2743207894 creator A5071796379 @default.
• W2743207894 creator A5074296532 @default.
• W2743207894 creator A5077911514 @default.
• W2743207894 date "2018-05-09" @default.
• W2743207894 modified "2023-10-17" @default.
• W2743207894 title "Correlations of CTLA‐4 exon‐1 49 A/G and promoter region 318C/T polymorphisms with the therapeutic efficacy of 131 I radionuclide in graves’ disease in Chinese Han population" @default.
• W2743207894 cites W1940731274 @default.
• W2743207894 cites W1982567339 @default.
• W2743207894 cites W1990844699 @default.
• W2743207894 cites W2012293367 @default.
• W2743207894 cites W2045393123 @default.
• W2743207894 cites W2049940928 @default.
• W2743207894 cites W2065899910 @default.
• W2743207894 cites W2083402623 @default.
• W2743207894 cites W2085567820 @default.
• W2743207894 cites W2175101940 @default.
• W2743207894 cites W2199105679 @default.
• W2743207894 cites W2227593092 @default.
• W2743207894 cites W2268494033 @default.
• W2743207894 cites W2273599976 @default.
• W2743207894 cites W2284342954 @default.
• W2743207894 cites W2292664149 @default.
• W2743207894 cites W2322536062 @default.
• W2743207894 cites W2322548323 @default.
• W2743207894 cites W2324607802 @default.
• W2743207894 cites W2343166692 @default.
• W2743207894 cites W2520303211 @default.
• W2743207894 cites W4248005015 @default.
• W2743207894 cites W4249168454 @default.
• W2743207894 doi "https://doi.org/10.1002/jcb.26327" @default.
• W2743207894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28776731" @default.
• W2743207894 hasPublicationYear "2018" @default.
• W2743207894 type Work @default.
• W2743207894 sameAs 2743207894 @default.
• W2743207894 citedByCount "4" @default.
• W2743207894 countsByYear W27432078942019 @default.
• W2743207894 countsByYear W27432078942020 @default.
• W2743207894 countsByYear W27432078942021 @default.
• W2743207894 countsByYear W27432078942022 @default.
• W2743207894 crossrefType "journal-article" @default.
• W2743207894 hasAuthorship W2743207894A5000868340 @default.
• W2743207894 hasAuthorship W2743207894A5003520375 @default.
• W2743207894 hasAuthorship W2743207894A5015425896 @default.
• W2743207894 hasAuthorship W2743207894A5024332545 @default.
• W2743207894 hasAuthorship W2743207894A5026035167 @default.
• W2743207894 hasAuthorship W2743207894A5028256671 @default.
• W2743207894 hasAuthorship W2743207894A5044622075 @default.
• W2743207894 hasAuthorship W2743207894A5047278332 @default.
• W2743207894 hasAuthorship W2743207894A5047564239 @default.
• W2743207894 hasAuthorship W2743207894A5058986343 @default.
• W2743207894 hasAuthorship W2743207894A5059263184 @default.
• W2743207894 hasAuthorship W2743207894A5063749738 @default.
• W2743207894 hasAuthorship W2743207894A5071796379 @default.
• W2743207894 hasAuthorship W2743207894A5074296532 @default.
• W2743207894 hasAuthorship W2743207894A5077911514 @default.
• W2743207894 hasConcept C104317684 @default.
• W2743207894 hasConcept C126322002 @default.
• W2743207894 hasConcept C134018914 @default.
• W2743207894 hasConcept C151956035 @default.
• W2743207894 hasConcept C180754005 @default.
• W2743207894 hasConcept C197754878 @default.
• W2743207894 hasConcept C2776652619 @default.
• W2743207894 hasConcept C2908647359 @default.
• W2743207894 hasConcept C36823959 @default.
• W2743207894 hasConcept C526584372 @default.
• W2743207894 hasConcept C54355233 @default.
• W2743207894 hasConcept C71924100 @default.
• W2743207894 hasConcept C86803240 @default.
• W2743207894 hasConcept C90924648 @default.
• W2743207894 hasConcept C99454951 @default.
• W2743207894 hasConceptScore W2743207894C104317684 @default.
• W2743207894 hasConceptScore W2743207894C126322002 @default.
• W2743207894 hasConceptScore W2743207894C134018914 @default.
• W2743207894 hasConceptScore W2743207894C151956035 @default.
• W2743207894 hasConceptScore W2743207894C180754005 @default.
• W2743207894 hasConceptScore W2743207894C197754878 @default.
• W2743207894 hasConceptScore W2743207894C2776652619 @default.
• W2743207894 hasConceptScore W2743207894C2908647359 @default.
• W2743207894 hasConceptScore W2743207894C36823959 @default.
• W2743207894 hasConceptScore W2743207894C526584372 @default.
• W2743207894 hasConceptScore W2743207894C54355233 @default.
• W2743207894 hasConceptScore W2743207894C71924100 @default.
• W2743207894 hasConceptScore W2743207894C86803240 @default.
• W2743207894 hasConceptScore W2743207894C90924648 @default.

• next